Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Predictiv Care Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. Both matters are assigned to 1 examiner and 1 art unit, so the portfolio presents a shared examination setting rather than examiner or art-unit dispersion.
LIU, GUOZHEN is the busiest examiner, with 2 pending matters. Counsel can coordinate responses around one examiner relationship while keeping the arguments and claim amendments for each pending action procedurally distinct.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, GUOZHEN | 2 | 48.1% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18298614 | DISEASE OR DRUG ASSOCIATION PROVIDING SYSTEM FOR DIGITAL TWINS WITH GENETIC INFORMATION SCREENED BY ARTIFICIAL INTELLIGENCE | LIU, GUOZHEN | — |
| 18298462 | GENE-BASED DIGITAL TWIN SYSTEM THAT CAN PREDICT MEDICAL RISK | LIU, GUOZHEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18298614 | DISEASE OR DRUG ASSOCIATION PROVIDING SYSTEM FOR DIGITAL TWINS WITH GENETIC INFORMATION SCREENED BY ARTIFICIAL INTELLIGENCE | LIU, GUOZHEN | — |
| 18298462 | GENE-BASED DIGITAL TWIN SYSTEM THAT CAN PREDICT MEDICAL RISK | LIU, GUOZHEN | — |
| Art Unit | Apps |
|---|---|
| 1686 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18298614 | DISEASE OR DRUG ASSOCIATION PROVIDING SYSTEM FOR DIGITAL TWINS WITH GENETIC INFORMATION SCREENED BY ARTIFICIAL INTELLIGENCE | LIU, GUOZHEN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 18298462 | GENE-BASED DIGITAL TWIN SYSTEM THAT CAN PREDICT MEDICAL RISK | LIU, GUOZHEN | 1686 | §101§103§112DP | Non-Final OA | — | Pending | Apr 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPredictiv Care Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Guozhen Liu has the most, with 2 of Predictiv Care Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
